Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 37 Prostatic Neoplasms 19 Multiple Myeloma 17 Neoplasm Metastasis 14 Osteoporosis 8 Neuroblastoma 6 Pain 5 Osteosarcoma 5 Neoplasms, Plasma Cell 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Lung Neoplasms 4 Carcinoma, Renal Cell 4 Sarcoma, Ewing 3 Bone Diseases, Metabolic 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Osteonecrosis 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Kidney Neoplasms 2 Humoral Hypercalcemia Of Malignancy 2 Giant Cell Tumor of Bone 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Adenocarcinoma 2

Interventions

Gemcitabine 15 Doxorubicin 8 Docetaxel 8 Radiotherapy 7 Trabectedin 6 Nivolumab 5 pazopanib 4 liposomal doxorubicin 3 Sunitinib 3 Dacarbazine 3 pembrolizumab 2 eribulin 2 durvalumab 2 avelumab 2 Specimen Handling 2 Radiation Dose Hypofractionation 2 Letrozole 2 Ifosfamide 2 Bevacizumab 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tremelimumab 1 temsirolimus 1 sotigalimab 1 selinexor 1 sargramostim 1 rucaparib 1 ribociclib 1 regorafenib 1 pegfilgrastim 1 olaratumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyosarcoma × Zoledronic Acid × Clear all

NCT05080790 2025-08-17

DiTuSarc

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡